Wedbush Securities Inc. lessened its stake in Cerner Co. (NASDAQ:CERN) by 13.2% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 8,099 shares of the company’s stock after selling 1,237 shares during the quarter. Wedbush Securities Inc.’s holdings in Cerner were worth $522,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Icon Wealth Partners LLC acquired a new stake in shares of Cerner during the 2nd quarter worth about $102,000. Moneta Group Investment Advisors LLC raised its position in shares of Cerner by 3,608.5% during the 2nd quarter. Moneta Group Investment Advisors LLC now owns 31,411 shares of the company’s stock worth $124,000 after acquiring an additional 30,564 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its position in shares of Cerner by 155.7% during the 3rd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 2,347 shares of the company’s stock worth $151,000 after acquiring an additional 1,429 shares in the last quarter. Qube Research & Technologies Ltd raised its position in shares of Cerner by 85.4% during the 2nd quarter. Qube Research & Technologies Ltd now owns 2,898 shares of the company’s stock worth $173,000 after acquiring an additional 1,335 shares in the last quarter. Finally, Raymond James Trust N.A. acquired a new stake in shares of Cerner during the 3rd quarter worth about $201,000. Institutional investors and hedge funds own 77.70% of the company’s stock.

CERN has been the topic of several research analyst reports. KeyCorp raised their target price on Cerner from $74.00 to $76.00 and gave the stock an “overweight” rating in a research report on Monday, August 20th. BidaskClub lowered Cerner from a “hold” rating to a “sell” rating in a research report on Friday, August 31st. Cantor Fitzgerald reissued a “buy” rating and set a $80.00 target price on shares of Cerner in a research report on Wednesday, September 12th. Barclays began coverage on Cerner in a research report on Thursday, September 13th. They set an “equal weight” rating and a $70.00 price target on the stock. Finally, Zacks Investment Research lowered Cerner from a “hold” rating to a “sell” rating in a research report on Monday, October 8th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and eleven have given a buy rating to the company’s stock. Cerner currently has a consensus rating of “Hold” and an average target price of $69.86.

NASDAQ:CERN opened at $53.73 on Friday. The company has a market capitalization of $18.08 billion, a PE ratio of 24.42, a P/E/G ratio of 1.79 and a beta of 0.96. The company has a current ratio of 2.63, a quick ratio of 2.60 and a debt-to-equity ratio of 0.09. Cerner Co. has a 12-month low of $50.91 and a 12-month high of $73.43.

Cerner (NASDAQ:CERN) last released its earnings results on Thursday, October 25th. The company reported $0.57 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.01). The company had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.36 billion. Cerner had a net margin of 15.72% and a return on equity of 14.73%. Equities analysts predict that Cerner Co. will post 2.22 earnings per share for the current year.

In other news, President Zane M. Burke sold 381,139 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $64.05, for a total value of $24,411,952.95. Following the transaction, the president now owns 59,539 shares of the company’s stock, valued at $3,813,472.95. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, President Zane M. Burke sold 283,539 shares of the business’s stock in a transaction that occurred on Tuesday, September 11th. The shares were sold at an average price of $63.68, for a total value of $18,055,763.52. Following the completion of the transaction, the president now directly owns 59,539 shares in the company, valued at approximately $3,791,443.52. The disclosure for this sale can be found here. In the last three months, insiders sold 1,354,678 shares of company stock worth $82,344,416. Corporate insiders own 4.71% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Wedbush Securities Inc. Sells 1,237 Shares of Cerner Co. (CERN)” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2018/12/08/wedbush-securities-inc-sells-1237-shares-of-cerner-co-cern.html.

Cerner Company Profile

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Further Reading: What factors cause inflation to rise?

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.